Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
Landen CN, Merritt WM, Mangala LS, Sanguino AM, Bucana C, Lu C, Lin YG, Han LY, Kamat AA, Schmandt R, Coleman RL, Gershenson DM, Lopez-Berestein G, Sood AK. Landen CN, et al. Among authors: schmandt r. Cancer Biol Ther. 2006 Dec;5(12):1708-13. doi: 10.4161/cbt.5.12.3468. Epub 2006 Dec 30. Cancer Biol Ther. 2006. PMID: 17106249 Free article.
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL, Gershenson DM, Schmandt R, Cole SW, Lopez-Berestein G, Sood AK. Halder J, et al. Among authors: schmandt r. Clin Cancer Res. 2006 Aug 15;12(16):4916-24. doi: 10.1158/1078-0432.CCR-06-0021. Clin Cancer Res. 2006. PMID: 16914580 Free PMC article.
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
Merritt WM, Thaker PH, Landen CN Jr, Deavers MT, Fletcher MS, Lin YG, Han LY, Kamat AA, Schmandt R, Gershenson DM, Kinch MS, Sood AK. Merritt WM, et al. Among authors: schmandt r. Cancer Biol Ther. 2006 Oct;5(10):1357-60. doi: 10.4161/cbt.5.10.3225. Epub 2006 Oct 31. Cancer Biol Ther. 2006. PMID: 16969087 Free article.
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN Jr, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS, Merritt WM, Lin YG, Gao C, Schmandt R, Kamat AA, Li Y, Thaker P, Gershenson DM, Parikh NU, Gallick GE, Kinch MS, Sood AK. Landen CN Jr, et al. Among authors: schmandt r. J Natl Cancer Inst. 2006 Nov 1;98(21):1558-70. doi: 10.1093/jnci/djj414. J Natl Cancer Inst. 2006. PMID: 17077358
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK. Mangala LS, et al. Among authors: schmandt r. Clin Cancer Res. 2009 Jun 1;15(11):3770-80. doi: 10.1158/1078-0432.CCR-08-2306. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470734 Free PMC article.
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Lee JW, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK. Lee JW, et al. Among authors: schmandt r. J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205. doi: 10.1093/jnci/djp231. Epub 2009 Jul 29. J Natl Cancer Inst. 2009. PMID: 19641174 Free PMC article.
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Lu C, Shahzad MM, Moreno-Smith M, Lin YG, Jennings NB, Allen JK, Landen CN, Mangala LS, Armaiz-Pena GN, Schmandt R, Nick AM, Stone RL, Jaffe RB, Coleman RL, Sood AK. Lu C, et al. Among authors: schmandt r. Cancer Biol Ther. 2010 Feb;9(3):176-82. doi: 10.4161/cbt.9.3.10635. Epub 2010 Feb 16. Cancer Biol Ther. 2010. PMID: 20009575 Free PMC article.
68 results